Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Pfizer (NY: PFE)
43.51 USD  +0.30 (+0.69%)
Official Closing Price  /  Updated: 6:55 PM EST, Nov 16, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 23,343,900
Open 43.10
Bid (Size) 43.53 (4)
Ask (Size) 43.64 (6)
Prev. Close 43.21
Today's Range 42.91 - 43.78
52wk Range 33.20 - 45.81
Shares Outstanding 5,849,571,048
Dividend Yield 3.13%
Performance
YTD
+19.40%
+19.40%
1 Month
-2.38%
-2.38%
3 Month
+3.37%
+3.37%
6 Month
+22.08%
+22.08%
1 Year
+22.36%
+22.36%
Top News
More News
UPDATE 2-Pfizer to raise US drug prices in January after previously backing down
Pfizer Inc said on Friday that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous planned price increases this summer under pressure from President Donald... Read More
category companyNews
from Reuters: Company News
UPDATE 1-Pfizer plans to increase U.S. drug prices in January
Pfizer Inc said on Friday that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous price increases this summer under pressure from President Donald Trump. Read More
category companyNews
from Reuters: Company News
More News
Read More
Pfizer to raise prices on 41 prescription drugs next year despite pressure from Trump
category Medical biotechnology industry , Health Care/Pharmaceuticals Biotechnology and Life Sciences , Health Care , and 6 more.
from CNBC.com News
Pfizer plans to increase U.S. drug prices in January
category companyNews
from Reuters: Company News
Better Buy: EXACT Sciences Corporation vs. Illumina
category PACB , Market News , PFE , and 2 more.
from Motley Fool
Trump's Biopharma Impasse Led To A Slowdown — Now Pfizer Is Fighting Back
from Investor's Business Daily
A grandpa's hope for hemophilia cure leads him to gene therapy clinical trial
category Pfizer Inc , Health care industry , Biotechnology , and 10 more.
from CNBC.com News
Novartis launches third-to-market Remicade copy in Germany
category companyNews
from Reuters: Company News
How Trump's Standoff With Biopharma Led To A Sales Slowdown
from Investor's Business Daily
Most Active Equity Options & Strikes For Midday - Friday, Nov. 16
category Options
from Blogs - TalkMarkets
UPDATE 2-Pfizer loses drug patent fight in UK top court, may face claims
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.